Neurocrine wants to develop new obesity drugs. It’s making an acquisition to accelerate that move.

Finance
by
2 hours ago 0 2

Soleno Therapeutics’ stock is soaring on Monday in premarket after a report that Neurocrine is nearing a deal to buy the company.

Latest News
Finance
United Airlines wants even higher ticket prices. It’ll get them — with or without the Iran war.
44 minutes ago
0 0
How thieves move $1m in freight before anyone realizes it
Finance
How thieves move $1m in freight before anyone realizes it
47 minutes ago
0 0
Finance
Corporate insiders’ stock-market moves don’t match the headlines. Here’s what they’re seeing.
1 hour ago
0 0

Leave a Reply

Your email address will not be published. Required fields are marked *

[aces-bonuses-1 items_number="1" external_link="1" category="" items_id="" exclude_id="" parent_id="" columns="1" order="" orderby="" title=""]

© Copyright 2026 Glen Dross | Powered by WordPress | Mercury Theme
© Copyright 2026 Glen Dross
Powered by WordPress | Mercury Theme

Powered by
►
Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.
None
►
Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.
None
►
Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.
None
►
Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.
None
Powered by